Avecho Biotechnology Ltd (ASX:AVE, OTC:AVEFF, FRA:OEZ) has completed the treatment phase for the final patient required for ...
USA: A post-hoc analysis of phase III clinical trials suggests that tralokinumab demonstrates consistent efficacy and a ...
Impact of body mass index on immunotherapy outcomes and complications in solid tumor patients: A real-world evidence analysis. Median progression-free survival, mo (95% CI) 4.6 (3.4, 7.4) 4.6 (3.6, ...
Investors new to biotech and pharma stocks can get a quick overview of a company's pipeline health with phase success rates. A leading biotech trade group has broken down success rates by phase and ...
Neoadjuvant treatment with disitamab vedotin plus perioperative toripalimab in patients with muscle-invasive bladder cancer (MIBC) with HER2 expression: Updated efficacy and safety results from the ...
IgA nephropathy, the most common primary glomerulopathy worldwide, is a kidney disorder of B-cell origin characterized by mesangial accumulation of IgA-containing immune complexes. In at least 50% of ...
The intention of this publication is to provide Member States with examples of the analysis phase to form the foundation of SAT-based training programmes. Although methods of analysis vary, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results